In the ranking of the Listed Company of the Year, organized by Puls Biznesu and Bankier.pl, OncoArendi Therapeutics took second place in the category “Innovation in products and services”.
“We are pleased with the distinction and recognition by the capital market of OncoArendi Therapeutics’ innovative research and development of new drugs. This is a great success for a company which has been listed on the stock exchange for less than a year, and yet has overtaken many larger companies in the ranking, with much longer stock exchange experience. This is the reward of the whole OncoArendi team, whose passion and commitment and daily, hard work brings us closer to the goal set “- says Marcin Szumowski, president and significant shareholder of OncoArendi Therapeutics.
The ranking was based on surveys sent to nearly 100 analysts, managers and brokers, who selected and evaluated the best companies listed on the Warsaw Stock Exchange on five categories: board competence, investor relations, success in 2018, development prospects and innovation of products and services.
In the overall ranking, OncoArendi Therapeutics has been ranked 21st out of the top 30 rated companies from the WSE main market.
Information on the ranking on the website: https://www.pb.pl/gsr/o-rankingu